Sexual Health Impact of Using Pre-exposure HIV Prophylaxis

University Hospital, Clermont-Ferrand7 sites in 1 country56 target enrollmentApril 1, 2022

ConditionsPre-exposure HIV Prophylaxis (PrEP)

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Pre-exposure HIV Prophylaxis (PrEP)
Sponsor: University Hospital, Clermont-Ferrand
Enrollment: 56
Locations: 7
Primary Endpoint: Sexual health satisfaction
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Epidemiological and psychosociological survey of people on pre-exposure HIV prophylaxis (PrEP).

Detailed Description

This study is perform to study the sexual health satisfaction of men who have sex with men (MSM), since the use pre-exposure HIV prophylaxis (PrEP), compared to the time before PrEP.

Registry

clinicaltrials.gov

Start Date

April 1, 2022

End Date

March 12, 2023

Last Updated

3 years ago

Study Type

Observational

Sex

Male

Investigators

Sponsor

University Hospital, Clermont-Ferrand

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Adult patient, male having sex with men, not infected with HIV, and using HIV prophylaxis by pre-exposure treatment (PrEP) for at least 1 year, received in consultation for renewal of this prescription.
•Able to give his non-opposition to participate in the research.
•Affiliation to a social security scheme.

Exclusion Criteria

•Patient under curatorship/guardianship or safeguard of justice
•Refusal to participate

Outcomes

Primary Outcomes

Sexual health satisfaction

Time Frame: 1 day during the scheduled consultation

To study the sexual health satisfaction of men who have sex with men (MSM), since the use of HIV prophylaxis by pre-exposure treatment (PrEP), compared to the time before PrEP.